Sarepta Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +201.5% | +114.2% | +31.3% | +24.6% | +12.8% | +13.8% | +6.7% | +7.6% | +3.1% | +8.8% | +4.6% | +1.1% | +13.5% | +20.8% | +4.8% | +0.8% | +1.2% | +11.7% | +15.4% | +6.4% | +4.7% | +10.7% | -1.4% | +12.2% | -1.9% | +3.1% | +27.0% | +19.6% | +4.2% | -12.2% | +28.7% | +40.9% | +13.1% | -18.0% | -34.6% | +10.9% | +65.0% | -45.1% | – | |
| – | -99.6% | +93.8% | +111.9% | +476.4% | +15.2% | +57.4% | +20.7% | +29.8% | +50.3% | -8.2% | +32.0% | -18.1% | +19.4% | -18.9% | +5.7% | +12.5% | +49.2% | -0.3% | -12.7% | +20.1% | +35.4% | -0.9% | +20.2% | +5.7% | -22.9% | +13.7% | -2.6% | +8.5% | +19.3% | +14.4% | -11.9% | +105.8% | +44.3% | +4.0% | +10.9% | -1.2% | +164.4% | -70.1% | +25.2% | – | |
| – | – | +204.1% | +114.3% | +24.4% | +25.3% | +9.8% | +13.2% | +4.4% | +2.2% | +5.1% | +5.1% | +9.2% | -1.7% | +19.5% | +22.7% | +3.9% | -4.8% | +1.5% | +16.0% | +14.8% | +2.3% | +5.7% | +9.1% | -2.7% | +19.6% | -4.0% | +4.0% | +29.8% | +19.6% | +2.9% | -12.3% | +17.9% | +40.1% | +15.4% | -24.5% | -45.8% | -82.2% | +1,282.5% | -58.8% | – | |
| – | +106.0% | -58.8% | +102.3% | -41.9% | +29.8% | +4.0% | +165.9% | -29.5% | +68.9% | -38.1% | +25.1% | +18.3% | +66.6% | -39.0% | +38.5% | +1.0% | +8.8% | -5.8% | +22.8% | -41.9% | +41.8% | -1.5% | +29.9% | -14.1% | -1.3% | +14.9% | -1.5% | -19.7% | +0.6% | +2.5% | -10.3% | +24.9% | -10.9% | +286.8% | -73.6% | +7.1% | +48.6% | -52.7% | -40.7% | – | |
| – | -8.1% | +28.6% | +28.4% | -16.3% | +13.5% | +35.5% | +13.9% | +7.4% | +21.1% | -5.7% | +11.3% | +11.9% | +7.9% | +1.7% | -11.0% | +2.3% | +14.2% | -17.3% | +1.7% | -15.5% | +27.7% | -8.0% | +114.8% | -32.1% | +15.0% | -8.1% | +7.1% | +2.0% | +8.9% | -3.6% | +9.3% | -7.6% | +27.8% | -18.5% | +3.2% | -33.4% | +39.6% | -15.1% | -1.2% | – | |
| – | +65.7% | -40.9% | +71.6% | -33.5% | +21.7% | +16.8% | +92.1% | -18.9% | +50.6% | -28.2% | +19.5% | +15.9% | +50.2% | -30.4% | +19.8% | +1.4% | +10.3% | -5.8% | +12.9% | -35.8% | +37.5% | -3.4% | +52.8% | -20.9% | +4.0% | +6.6% | +1.1% | -12.5% | +3.9% | +0.0% | -2.7% | +10.7% | +3.2% | +149.1% | -62.2% | +2.6% | +29.5% | -44.5% | -5.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +41.7% | -102.0% | – | +628.4% | -285.8% | – | -189.5% | – | – | -96.3% | – | |
| – | -72.7% | +350.9% | +3.1% | +202.6% | +148.1% | +283.6% | +6.7% | +31.1% | -32.1% | +1.2% | +1.2% | +1.2% | +11.6% | +62.3% | +0.7% | +1.3% | +34.9% | -16.4% | +1.2% | +1.0% | +0.3% | -1.6% | +1.5% | -8.1% | -54.6% | -5.5% | -17.4% | +0.1% | +0.1% | -20.4% | +16.0% | +1.8% | -9.0% | +0.6% | +16.1% | +44.7% | +0.0% | +187.0% | -0.9% | – | |
| – | – | – | -173.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +2.7% | -67.2% | +150.5% | +405.0% | -323.3% | – | -226.3% | – | – | -100.5% | – | |
| – | – | – | -105.5% | – | -191.6% | – | +347.5% | -208.4% | – | – | +107.1% | +29.9% | +214.6% | -83.8% | -82.6% | +380.0% | +766.7% | -117.2% | – | – | -61.2% | +855.4% | +285.4% | -61.0% | +501.4% | -49.0% | +131.3% | -17.0% | -168.1% | – | +33.6% | -94.4% | +3,113.7% | +404.1% | -167.6% | – | – | +168.4% | -74.3% | – | |
| – | – | – | -175.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -20.9% | -82.1% | +420.3% | +373.2% | -381.4% | – | -191.4% | – | – | -101.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -4,820.3% | – | – | – | – | – | – | – | – | – | – | – | – | -1,289.2% | – | -4.6% | -50.1% | +79.6% | +283.1% | -297.7% | – | -199.0% | – | – | -92.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.